open access

Ahead of print
Letter to the Editors
Published online: 2020-10-02
Submitted: 2020-08-12
Accepted: 2020-09-03
Get Citation

Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure — what is the risk of COVID-19?

Łukasz Rzepiński, Sławomir Wawrzyniak, Zdzisław Maciejek
DOI: 10.5603/PJNNS.a2020.0072
·
Pubmed: 33006133

open access

Ahead of print
Letter to the Editors
Published online: 2020-10-02
Submitted: 2020-08-12
Accepted: 2020-09-03

Abstract

Not available

Abstract

Not available
Get Citation

Keywords

myasthenia gravis, immunosuppression, COVID-19

About this article
Title

Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure — what is the risk of COVID-19?

Journal

Neurologia i Neurochirurgia Polska

Issue

Ahead of print

Published online

2020-10-02

DOI

10.5603/PJNNS.a2020.0072

Pubmed

33006133

Keywords

myasthenia gravis
immunosuppression
COVID-19

Authors

Łukasz Rzepiński
Sławomir Wawrzyniak
Zdzisław Maciejek

References (6)
  1. Morren J, Li Y. Maintenance immunosuppression in myasthenia gravis, an update. J Neurol Sci. 2020; 410: 116648.
  2. Jacob S, Muppidi S, Guidon A, et al. International MG/COVID-19 Working Group. Guidance for the management of myasthenia gravis (MG) and Lambert-Eaton myasthenic syndrome (LEMS) during the COVID-19 pandemic. J Neurol Sci. 2020; 412: 116803.
  3. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19) 16-24 February 2020. Geneva: World Health Organization, 2020. www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf.
  4. Jaretzki A, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000; 55(1): 16–23.
  5. Anand P, Slama MCC, Kaku M, et al. COVID-19 in patients with myasthenia gravis. Muscle Nerve. 2020; 62(2): 254–258.
  6. Thng ZX, De Smet MD, Lee CS, et al. COVID-19 and immunosuppression: a review of current clinical experiences and implications for ophthalmology patients taking immunosuppressive drugs. Br J Ophthalmol. 2020 [Epub ahead of print].

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl